| Experiment ID | EXP00301 |
| Reference | Title: Whole-genome characterization of chemoresistant ovarian cancer. Author: Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J,Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, Kassahn KS,Newell F, Quinn MC, Kazakoff S, Quek K, Wilhelm-Benartzi C, Curry E, Leong HS; Australian Ovarian Cancer Study Group, Hamilton A,Mileshkin L, Au-Yeung G, Kennedy C, Hung J, Chiew YE, Harnett P, Friedlander M, Quinn M, Pyman J, Cordner S, O'Brien P,Leditschke J, Young G, Strachan K, Waring P, Azar W, Mitchell C, Traficante N, Hendley J, Thorne H, Shackleton M, Miller DK,Arnau GM, Tothill RW, Holloway TP, Semple T, Harliwong I, Nourse C, Nourbakhsh E, Manning S, Idrisoglu S, Bruxner TJ, Christ AN,Poudel B, Holmes O, Anderson M, Leonard C, Lonie A, Hall N,Wood S, Taylor DF, Xu Q, Fink JL, Waddell N, Drapkin R,Stronach E, Gabra H, Brown R, Jewell A, Nagaraj SH, Markham E,Wilson PJ, Ellul J, McNally O, Doyle MA, Vedururu R, StewartC, Lengyel E, Pearson JV, Waddell N, deFazio A, Grimmond SM,Bowtell DD. Journal: Nature. 2015 May 28;521(7553):489-94. doi: 10.1038/nature14410. Abstract: Erratum in Nature. 2015 Nov 19;527(7578):398. PMID: 26017449 |
| Expressiion Profile | Description: Whole genome characterisation of chemoresistant ovarian cancer [NanoString miRNA] Organism: Homo sapiens GEO ID: GSE65819 Platform: GPL19765 Number of samples: 121 |
| Design and Sample | Cancer Type: ovarian cancer Cancer SubType: N/D Cell Line: N/D Experimental Design: cancer vs normal Case Sample: ovarian cancer Control Sample: normal tissue Num of Case: 114 Num of Control: 7 Quantification Software: Limma Num of miRNAs: 800 |
| Identification | Num of Up: 126 Num of Down: 175 |